Pfizer Embarks on Massive Internal Reorganization

The international pharmaceutical company, Pfizer, has announced a plan to break its entire structure into three segments, two focused on their Innovative line and one on their Value line.  Pfizer…
Read More

Cancer Advocacy Coalition of Canada Advocates Better Access to Innovative Treatments

In this year’s “Report Card on Cancer in Canada”, the Cancer Advocacy Coalition of Canada praises the progress of cancer research, but asks that Canadians be given better access to…
Read More

How Big and Little Pharmaceutical Companies Bring New Drugs to Market

For the pharmaceutical industry, small, lean and agile research firms are the growing trend. Research in the life sciences, as in the cutting edge of any field in Canada, follows…
Read More

Fraser Institute Proposes International Pharmaceutical Patent Reform

The Fraser Institute, a leading Canadian public policy think tank, has joined the chorus of voices asking to extend the life of Canadian pharmaceutical patents. Their report, released this month,…
Read More

Life Sciences Offer Women Ground-breaking Research Opportunities

STEM (Science, Technology, Engineering and Medicine) jobs are generally considered to be a vital part of the economy, and one of the hottest sectors for employment and education investment. As…
Read More

Top Canadian Pharmaceutical App Gets International Option

Last month, My MedRec went global. If you’re not familiar with the app, My MedRec is a free system designed on behalf of pharmaceutical industry representative association Rx&D. The iPhone…
Read More

Catastrophic Drug Plans to Span All Canadian Provinces

As of October, with the inclusion of New Brunswick, every Canadian province will have a catastrophic drug plan in place. These last resort measures protect families from medical bankruptcy and…
Read More

New Label Plan for Canadian Drugs

A new drug regulation was recently announced in Canada, this time controlling the packaging. That’s the Plain Language Labelling Initiative, which will be an overhaul of how drugs are described…
Read More

Pharmaceutical Quality Control and a Recent Recall

At the end of May, four companies announced a recall on five drugs commonly sold in Canada. The recall is not about a problem with the medications themselves, as a…
Read More

Rx&D Report Shows 34% Under Report Rate of Innovation Investment By Government Agencies

report by Rx&D, the Canadian association of pharmaceutical companies, confirms an ongoing trend of under-reporting of pharmaceutical innovation investment by government bodies. The report, released in May, shows a consistent…
Read More